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Abstract. Aminopeptidase I (API) is a soluble leucine 
aminopeptidase resident in the yeast vacuole (Frey, J., 
and K.H. Rohm. 1978. Biochim.  Biophys. Acta. 527:31- 
41). The precursor form of API contains an amino-ter- 
minal 45-amino acid propeptide, which is removed by 
proteinase B (PrB) upon entry into the vacuole. The 
propeptide of API lacks a consensus signal sequence 
and it has been demonstrated that vacuolar localization 
of API is independent of the secretory pathway (Klion- 
sky, D.J., R. Cueva, and D.S. Yaver. 1992. J. Cell Biol. 
119:287-299).  The predicted secondary structure for 
the API propeptide is composed of an amphipathic 
a-helix followed by a [3-turn and another a-helix, form- 
ing a helix-turn-helix structure. With the use of muta- 
tional analysis, we determined that the API propeptide 
is essential for proper transport into the vacuole. Dele- 
tion of the entire propeptide from the API molecule re- 
suited in accumulation of a mature-sized protein in the 
cytosol. A more detailed examination using random 
mutagenesis and a series of smaller deletions through- 
out the propeptide revealed that API localization is se- 
verely affected by alterations within the predicted first 
a-helix. In vitro studies indicate that mutations in this 
predicted helix prevent productive binding interactions 
from taking place. In contrast, vacuolar import is rela- 
tively insensitive to alterations in the second predicted 
helix of the propeptide. Examination of API folding re- 
vealed that mutations that affect entry into the vacuole 
did not affect the structure of API. These data indicate 
that the API propeptide serves as a vacuolar targeting 
determinant at a critical step along the cytoplasm to 
vacuole targeting pathway. 
I 
n  the yeast Saccharomyces cerevisiae soluble  proteins 
enter the vacuole through one of four mechanisms: 
autophagy (Hirsch et al., 1992; Tsukada and Ohsumi, 
1993; Thumm et al., 1994; reviewed in Seglen and Bohley, 
1992), endocytosis (reviewed in Nothwehr and Stevens, 1994; 
Raths et al., 1993; Riezman, 1993), the secretory pathway 
(reviewed in Pryer et al., 1992), and the cytoplasm to vacu- 
ole targeting pathway (Cvt; Klionsky et al., 1992; Harding 
et al., 1995). In both autophagy and endocytosis there is 
bulk flow of soluble proteins into the vacuole but to date 
no soluble resident vacuolar protein has been shown to en- 
ter the yeast vacuole by these means. 
The majority of resident yeast vacuolar proteins enter 
this organelle through the secretory pathway (reviewed in 
Stack and Emr, 1993). Contrary to autophagy and endocy- 
tosis, proteins that transit through the secretory pathway 
are  not  engulfed  by  membranes  but  are  translocated 
across  the endoplasmic reticulum (ER) membrane. In a 
series of vesicle-mediated transport steps, the proteins are 
carried from the ER through the subcompartments of the 
Golgi before being directed to the vacuole (reviewed in 
Pryer et  al.,  1992). Transit through this  portion  of the 
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secretory pathway has been carefully documented for a 
number of vacuolar hydrolases (reviewed in Klionsky et 
al., 1990). These proteins translocate across the ER mem- 
brane via an NH2-terminal  cleavable  signal sequence or 
noncleaved internal hydrophobic domain. The signal se- 
quence serves no further purpose once the protein has en- 
tered the ER. Delivery to the vacuole is dependent upon 
the presence of a second targeting signal. For all of the 
characterized soluble  hydrolases, this  targeting determi- 
nant has been shown to reside in a propeptide domain that 
is proteolytically  removed upon delivery to the vacuole. 
Two resident vacuolar enzymes, aminopeptidase  I (API)  1 
and a-mannosidase, have been found to enter the vacuole 
in  a  Sec-independent manner  (Yoshihisa  and  Anraku, 
1990; Klionsky et al., 1992). Very little is known about the 
mechanism by which  a-mannosidase enters the vacuole 
except that the protein contains a vacuolar targeting deter- 
minant within the last 157 amino acids (of 1,083 amino ac- 
ids total) of its carboxyl terminus (Yoshihisa and Anraku, 
1. Abbreviations used in this paper:. API, aminopeptidase I; CPY, carboxy- 
peptidase Y; cvt, cytoplasm to vacuole targeting; DPAP B, dipeptidyl ami- 
nopeptidase B; IB, import buffer; PGK, phosphoglycerate kinase; PrA, 
proteinase A; PrB, proteinase B; TX-100, Triton X-100; TTBS, Tween-20 
tris buffered saline; YNB, yeast nitrogen base; YPD, 1% bacto-yeast ex- 
tract, 2% bacto-peptone, 2% dextrose. 
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ing the vacuolar localization of API. Genetic studies in our 
laboratory have isolated a number of mutants that are de- 
fective in transporting API to the vacuole (Harding et al., 
1995). These cytoplasm to vacuole targeting (cvt) mutants 
are unaffected in their ability to transport proteins through 
the secretory pathway. In vitro studies have demonstrated 
that API targeting requires ATP, a functional vacuolar ATP- 
ase and a GTP-binding protein (Scott and Klionsky, 1996). 
An additional element essential to understanding cyto- 
plasm to vacuole targeting is identification of the vacuole 
sorting determinant that directs proteins to this pathway. 
Knowing the  targeting  information has  been  useful  in 
many instances for identifying or confirming components 
of the cellular sorting machinery for almost every eukary- 
otic organelle. For example, identification of the targeting 
determinants in carboxypeptidase Y (CPY; Johnson et al., 
1987; Valls et al., 1987) permitted a biochemical confirma- 
tion that Vpsl0p is the CPY receptor (Marcusson et al., 
1994). Similarly, analysis of protein import in peroxisomal 
assembly mutants revealed that the pas8 mutant was spe- 
cifically defective in the recognition of proteins using the 
previously identified peroxisomal  targeting signal  PTS1 
(SKL) (McCollum et al.,  1993).  In vitro translated PAS8 
protein was shown to bind the PTS1 signal suggesting its 
potential role as a  receptor.  Additional experiments in- 
cluding cross-linking to an SKL-containing peptide con- 
firmed  this  functional  role  for  Pas8p  (Terlecky  et  al., 
1995).  Finally, nuclear localization sequences have been 
used in ligand binding techniques to identify binding pro- 
teins that play a role in nuclear protein import (Lee and 
Melese, 1989; Silver, 1989). The isolation of p67, a nuclear 
localization sequence binding protein, was facilitated by 
conjugating the histone H2B nuclear localization sequence 
to an affinity column resin. This in turn led to its eventual 
cloning (Lee et al., 1991). 
Targeting signals also have been used as the basis for ge- 
netic selections or screens designed to identify proteins 
that comprise  the  targeting machinery. Hybrid proteins 
containing the HDEL or KKXX endoplasmic reticulum 
retention motifs were utilized to allow the isolation of the 
HDEL receptor (Pelham et al., 1988; Lewis et al., 1990) 
and Retlp, respectively (Letourneur et al., 1994), involved 
in  the  recapture  or  retention  of ER  resident  proteins. 
Identification of the trans-Golgi network (TGN) localiza- 
tion signals in the Kex2 protease (K. Redding, J. Brickner, 
and R.S. Fuller, personal communication) and dipeptidyl 
aminopeptidase A  (S. Nothwehr and T. Stevens, personal 
communication) has enabled the design of genetic screens 
that have led to the identification of genes involved in lo- 
calization  of these  late  Golgi  membrane  proteins.  Re- 
cently, a tyrosine-based sorting signal from a mammalian 
TGN  protein  was  used  to  identify interacting clathrin- 
associated  protein  complexes  through  the  yeast  two- 
hybrid system (Ohno et al., 1995). Finally, the sequestra- 
tion of the HIS4 or URA3 gene products fused behind an 
ER signal sequence or a  matrix targeting signal, respec- 
tively, were used in genetic selections to identify compo- 
nents of the ER translocation machinery (Deshaies  and 
Schekman, 1987) or mitochondrial protein import path- 
way (Maarse et al., 1992). 
Turning to the API molecule, the Chou-Fasman index 
(Chou and Fasman,  1974) for secondary structure  indi- 
cates that the API propeptide has a  predicted structure 
composed of an a-helix followed by a 13-turn and a second 
a-helix. A  helical wheel projection analysis of the helices 
revealed that the first a-helix is most likely amphipathic. 
The presence of an amphipathic a-helix in the propeptide 
is reminiscent of the propeptides of nuclear-encoded mito- 
chondrial  proteins.  Unlike  mitochondrial presequences, 
however, the amphipathic a-helix in the API propeptide 
contains both basic and acidic residues. Since targeting sig- 
nals are present in the propeptides of many vacuolar pro- 
teins, we focused our examination on the propeptide of API. 
We found that deleting the entire propeptide from API 
abrogated vacuolar localization. Smaller deletions within 
the propeptide combined with a series of random and site 
directed mutants indicated that the propeptide's amphi- 
pathic helix is responsible  for the  vacuolar targeting of 
API. The data reported here indicate that the API propep- 
tide is not necessary for folding of the mature portion of 
the API polypeptide but instead plays a direct role in the 
entry of API into the yeast vacuole. 
Materials and Methods 
Strains and Media 
Saccharomyces  cerevisiae yeast strains used in this study were DKY6224 
MATer  urn3-52  his3-A200  trpl-A901  ade2-101 pep4::LEU2  suc2-A9; 
DYY101 MATct leu2-3, 112 urn3-52 his3-A200 trpl-d901 ade2-101 suc2- 
A9 GAL Aapel::LEU2 (Klionsky et al., 1992);  SEY6210 MATct leu2-3, 
112 urn3-52 his3-A200 trpl-A901 lys2-801 suc2-A9 GAL (Robinson et al., 
1988);  TVY1  MATct leu2-3,  112 ura3-52  his3-A200  trpl-A901  lys2-801 
suc2-A9 GAL Apep4::LEU2  (Cereghino et al., 1995). 
Yeast strain DYY101 was backcrossed with strain SEY6211. The re- 
sulting progeny were backcrossed with strain SEY6210 to generate strain 
THY101 (MATer leu2-3, 112 ura3-52 his3-A200 trpl-A901 ade2-101 suc2- 
A9 GAL Aapel::LEU2).  Strain MOY101 (MATs leu2-3, 112 ura3-52 his3- 
3200 trpl-A901 ade2-101 suc2-d9 GAL Aapel::LEU2 Apep4::URA3)  was 
constructed as follows: The PEP4 gene was cloned into the plasmid pUC4. 
The HindIII fragment was deleted and replaced with the URA3 gene. This 
dpep4 knockout plasmid was obtained from Gustav Ammerer, (Biocen- 
trum Vienna, Austria). The plasmid was linearized with BamHI and used 
to transform strain THY101. Ura  + Leu+ colonies were selected and the 
absence of the APE1 and PEP4 gene products was confirmed by Western 
blot. 
Escherichia coli strains used in this study were BW313 HfrKL16 P0/45 
[lysA(61-62)]  dut-1  ung-1  thi-1  relA1  spoT-l;  MC1061  F-araD139 
A(araABOIC-leu)  7679 A(lac)x74  galU gall( rpsL hsr-  hsm+;  DH5et 
~b8OdlacZ AM15  fecal endA1 gyrA96 thi-1 hsdR17 (rr,  mr +) supE44 
relA1 doer A(lacZYA-augF) I]169. 
SLM medium (1  M  sorbitol,  1%  glucose, 1%  proline,  Wickerham's 
salts, pH 7.5; Guthrie and Fink, 1991), SMD medium (0.067% yeast nitro- 
gen base [YNB], 2% glucose, and vitamins and auxotrophic amino acids 
as required), and YPD medium (1% bacto-yeast extract, 2% bacto-pep- 
tone, 2% dextrose; Sherman et al., 1979) were used for growing yeast. LB 
medium (1% bacto-tryptone, 0.5% bacto-yeast extract, 0.5% NaCl) was 
used for growing E. coli. 
Reagents 
Autofluor was from National  Diagnostics, Inc.  (Manville, N J);  Immo- 
bilon-P was from Millipore Corp. (Bedford, MA); DNA restriction and 
modifying enzymes were from New England Biolabs, Inc. (Beverly, MA); 
GTG and LE agarose were from FMC BioProducts (Rockland, ME); lu- 
minol was from Sigma Chem. Co. (St. Louis, MO); lyticase was obtained 
from Enzogenetics (Corvallis, OR); papain and proteinase K were from 
Boehringer Mannheim Biochemicals (Indianapolis, IN); Sequenase was 
from  United  States  Biochemicals  (Cleveland,  OH);  35Sequetide  and 
Expre35S35S-label  were from DuPont NEN Research Products (Boston, 
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from Bio-Rad Laboratories (Cambridge, MA); Wizard PCR purification 
system was from Promega (Madison, WI); and bacto-yeast extract, bacto 
peptone, and yeast nitrogen base without amino acids were from Difco 
Labs. (Detroit, MI). Antiserum to API was prepared as described (Klion- 
sky et al., 1992).  Antiserum to CPY and proteinase A  (PrA) were pre- 
pared as described (Klionsky et al., 1988). Antiserum to phosphoglycerate 
kinase (PGK) was generously provided by J. Thorner (Baum et aL, 1978). 
Goat anti-rabbit IgG-HRP antiserum was from Cappel (Durham, NC). 
Plasmid Construction 
A  single copy of the APE1 gene, which encodes the API enzyme (Cueva 
et al., 1989;  Chang and Smith, 1989),  was subcloned into the single copy 
number (centromeric) plasmid pRS414 (Sikorski and Hieter, 1989) to gen- 
erate the plasmid pfBAPIcAX as follows: a 2.1-kb BamHI fragment from 
pRN1, encoding the promoter and the NH2-terminal first 400 amino acids 
of the API ORF, was cloned into the BamHI site within the polylinker of 
pRS414  resulting in the plasmid pAPIBamc. The resulting pAPIBamc 
plasmid  was  then  restriction  digested  with  KpnI,  cleaving within  the 
polylinker and 382 bp from the 3' end of the APEI BamHI fragment. A 
1.5-kb  KpnI  fragment from  pRN1,  encoding the  COOH-terminal  227 
amino acids of the API ORF, was cloned into the pAPIBamc plasmid, re- 
storing the APE1 gene to full-length and resulting in the pfAPIc plasmid. 
The XhoI site at the 3' end of the APE1 gene was destroyed as follows: a 
Notl and a partial XhoI digest of the plasmid pfAPlc was performed to 
isolate the APE1 gene. The plasmid pRS414 was digested with XhoI and 
the restriction site overhang was filled in with the Klenow fragment of 
DNA polymerase I. The newly synthesized blunt ends were ligated to pro- 
duce pRS414AX, where the XhoI site was destroyed. The NotI/Xhol frag- 
ment  of  the  APE1  gene  was  then  ligated  into  a  Notl/SalI  digested 
pRS414AX plasmid, destroying the XhoI site at the 3' end of the APE1 
gene by ligating it to the compatible SalI cohesive end, yielding the pfAPI- 
cAX  plasmid.  Finally,  the  filamentous  phage  origin  of  replication  in 
pfAPIcAX was used to synthesize a single stranded DNA template in the 
E. coil dut ung strain BW313 (el-Hajj et al., 1992).  An oligonucleotide was 
synthesized starting at nucleotide -28 of the APE1 gene and ending at 
nucleotide 11 (Cueva et al., 1989; Chang and Smith, 1989) and encoding a 
BglII restriction site at nucleotide -10 (APIBGL5, 5'CCA ACA AAA 
TTA AAA CAA GAT CTA AAA GAA TGG). This oligonucleotide 
and DNA template were used in an in vitro extension reaction to intro- 
duce a  BgllI restriction site into the APE1 gene, 8  bp upstream of the 
ATG start codon (Kunkel, 1985; Kunkel et al., 1987) and yielded the final 
product pfBAPIcAX. The pfBAPIcAX plasmid was used for mutagenesis 
of the DNA encoding the API propeptide and the subsequent expression 
of the altered API. Routine molecular biology methods were carried out 
according to Sambrook (Sambrook et al., 1989). 
Propeptide Deletion Construction 
The  A2-45,  A4-13,  and  A31-40 deletions  in  the  propeptide  were  con- 
structed  as  follows:  a  1.8-kb  BamHI/XbaI  fragment from the  plasmid 
pRN1 (Klionsky et al., 1992) was ligated into the BamHI/XbaI sites of the 
M13 rap19 vector. Single strand DNA was prepared and used for a tem- 
plate  in  dut  ung  mutagenesis by  the  Kunkel  method  (Kunkel,  1985; 
Kunkel et al., 1987).  The mutagenic oligonucleotide primers were as fol- 
lows:  APIA4-13,  5'  GAA TGG  AGG  AAA  CTC  TGC  AGA  TGC; 
APIA31-40, 5'CAA ATC GCC AAC TCG TGG TGC ATC C; APIA2- 
45, 5'CAA GAA AAA AAA GAA TGG AGC ACA ATT ATG AGG. 
The  BamHI/XbaI  fragment containing the mutated DNA was  excised 
from mp19 and ligated into the BamHI/XbaI sites of pSEYC306 (Johnson 
et al., 1987). A  1.5-kb XbaI/SalI fragment from pRN1 was cloned at the 3' 
end of this insert by ligating into the Xbal/SalI sites to generate the full- 
length APE1 gene containing the propeptide deletions. 
Random Mutagenesis 
Random mutants in the API propeptide-encoding regions were generated 
by PCR mutagenesis as described by Muhlrad et al. (1992).  In our mu- 
tagenesis the oligonucleotide primers used were: RSFWD starting at nu- 
cleotide 2055 and ending at nucleotide 2032 of the plasmid pRS414, 5'- 
GAC CAT GAT TAC GCC AAG CGC GCA; and APIPCRM1 starting 
at nucleotide 211 and ending at nucleotide 188 of the APE1 gene, 5'-ACT 
ACA TGG TAA GTG GTA GGG "I'TC. For mutagenesis, the PCR reac- 
tions were conducted with a disproportionate level of either adenosine or 
guanosine (one-tenth the concentration of the three other nucleotides). 
The PCR reactions were titrated with 0 to 8 mM MnCI  2 to determine a 
MnCI  2 concentration where the yield of amplified product dropped  to 
~50% of that in the 0 mM MnCI2 reaction (Muhlrad et al., 1992). The re- 
suiting PCR product was separated from excess primer and nucleotide by 
passage through a  Wizard PCR purification matrix. The purified PCR 
product was added to a yeast transformation reaction in the presence of 
pfBAPIcAX, which had been restriction gapped with BgllI and Xhol. The 
resulting  transformation/recombination  product  incorporated  mutated 
DNA in place of the absent propeptide-encoding DNA of the pfBAPIcAX 
plasmid. To identify mutants, protein extracts were prepared from trans- 
formants and analyzed by Western blot using antiserum to API (Klionsky 
et al., 1992).  Mutations were confirmed by dideoxy sequencing. The per- 
centage of transformants containing a mutation was ~5 %. 
Directed Mutagenesis 
Site  directed  mutagenesis was carried  out  via PCR,  using the  "mega- 
primer" method of incorporating mutations (Landt et al., 1990; Penin and 
Gilliland, 1990; Sarkar and Sommer, 1990;  Marini et al., 1993). The mu- 
tagenesis was carried  out in  two PCR reactions. The first reaction re- 
quired the use of the RSFWD primer and the mutagenic primer to amplify 
the promoter region and a portion of the API propeptide-encoding DNA, 
using the pfBAPIcAX plasmid as a  template. The second reaction used 
the APIPCRM1 primer and the product of the first reaction to extend the 
first product through the propeptide-encoding region to nucleotide 211 of 
the APE1 gene. The product was digested with BglII and XhoI and sub- 
cloned into pfBAPIcAX. Deletion mutations were screened by molecular 
mass shift of a BglII/XhoI restriction fragment on a 3 %/1% GTG/LE aga- 
rose gel and verified by dideoxy sequencing. Substitution mutations were 
screened by dideoxy sequencing. 
Pulse Chase Analysis and lmmunoprecipitation of  API 
Whole cell radiolabeling and API immunoprecipitation were carried out 
essentially as described previously (Klionsky et al., 1992). Yeast cells were 
grown to midlog phase (approximate OD~0 0.8), isolated by centrifuga- 
tion and incubated at 30°C. Cells were labeled with [35S]methionine for 20 
min followed by a nonradioactive chase for times indicated in the experi- 
ment. The chase reaction was terminated by the addition of trichloroacetic 
acid (TCA) to 10% and a protein extract was prepared by glass bead lysis. 
Immunoprecipitation  was  carried  out  at  4°C  using antiserum to  API 
(Klionsky et al., 1992). 
Spheroplast Preparation and SubceUular  Fractionation 
The  vacuolar localization  of API was  assayed as described  previously 
(Harding et al., 1995; Scott and Klionsky, 1995). Briefly, spheroplasts were 
subjected to differential osmotic lysis to gently lyse the plasma membrane 
while maintaining vacuolar integrity. One fraction was precipitated with 
10% TCA (Fig. 5, 7). Two other fractions were treated with 50 p~g/ml pro- 
teinase K  (30 rain at 4°C),  in the absence or presence of 0.1%  Triton 
X-100 (Fig. 5, T+Proteinase K, T+TX100) before precipitation with 10% 
TCA. Membrane pellet and supernatant fractions were separated by cen- 
trifuging at 5,000 g for 5 min. The supernatant (Fig. 5 S) containing cytosol 
was removed and both the supernatant and the pellet fractions (contain- 
ing vacuoles; Fig. 5 P) were precipitated with 10% TCA and prepared for 
SDS PAGE/Western blot analysis. 
Protease Studies 
Yeast cells were grown to midlog phase (approximate OD600 0.8), isolated 
by centrifugation and spheroplasted as described (Klionsky et al., 1992). 
Cells were radiolabeled with [35S]methionine for 15 min. The radiolabeled 
spheroplasts were washed with ice cold SLM, isolated by centrifugation, 
and resuspended to 10 ODt00/ml in 50 mM Tris, pH 7.5, 10 mM EDTA, 
0.2% Triton X-100 for proteinase K or 50 mM Tris, pH 6.8, 0.2% Triton 
X-100 for papain. Proteolytic digestion was carried out by the addition of 
proteinase K or papain to a final concentration of 50 p.g/ml. The papain 
and proteinase K  digests were incubated 30 min at 37 and 4°C, respec- 
tively. The digests were terminated by the addition of TCA to a concen- 
tration  of 10%.  Immunoprecipitation from the radiolabeled  digest  ex- 
tracts was carried  out at 4°C using antiserum to  API  (Klionsky et  al., 
Oda et al. Aminopeptidase I Cytoplasm to Vacuole Targeting Determinant  1001 1992). The immunoprecipitated API was analyzed by SDS PAGE and au- 
toradiographed. 
API Binding and In Vitro Import Studies 
20 OD60o equivalents of spheroplasts were pulse labeled for 5 min, pel- 
leted and resuspended in  IB  (100  mM sorbitol, 100 mM KCI, 50  mM 
KOAc, 20 mM K-Pipes, pH 6.8, 5 mM MgCl2). The resulting permeabi- 
lized cells were centrifuged at 5,000 g for 5 min. 20D600 equivalents of the 
resulting supernatant and pellet fractions were subjected to immunopre- 
cipitation, SDS PAGE and quantitation with a Fuji FUJIX BAS1000 Bio- 
imaging Analyzer (Fuji Medical Systems, USA, Stamford, CT). The re- 
maining 18 OD600 equivalents of the pellet fraction were subjected to in 
vitro import reactions (Scott and Klionsky, 1995). Briefly, the pellet frac- 
tion was resuspended in 1 ml IB containing 1 mM ATP, 40 mM phospho- 
creatine, and 0.2 mg/ml creatine kinase. The reactions were incubated at 
30°C for 2 h and API was immunoprecipitated from a vacuole-enriched 
fraction collected by flotation through a Ficoll gradient as described (Scott 
and Klionsky, 1995). 
Protein Electrophoresis and Immunoblotting 
All SDS PAGE was carried out as described (Laemmli, 1970).  Protein 
samples were resolved by SDS PAGE, transferred onto Immobilon-P and 
blocked in 5% nonfat milk in TTBS. The blots were probed with primary 
rabbit antiserum to API diluted 1:20,000 in TTBS, washed, probed with 
secondary goat anti-rabbit IgG conjugated to horseradish peroxidase, and 
then developed by luminol chemiluminescence. 
Results 
The API Propeptide Is Required 
for Vacuolar Localization 
API is synthesized as a precursor containing an amino-ter- 
minal  propeptide.  Analysis  of  the  Chou-Fasman  index 
(Chou and Fasman, 1974) for predicted secondary structure 
of the propeptide indicated the presence of two a-helices 
separated by a  13-turn (Fig.  1 A). A  helical wheel projec- 
tion  analysis of the  helices  indicated  that  the  first helix 
may form an amphipathic structure (Fig. 1 B). The partici- 
pation  of propeptides  in  the  transport  of a  majority of 
posttranslationally targeted proteins and the unusual pre- 
dicted secondary structure for the API propeptide led us 
to examine its role in vacuolar localization. 
We investigated the participation of the propeptide in 
vacuolar delivery through mutational analysis. Yeast cells 
disrupted  at  the  chromosomal APE1  locus  (DYY101) 
were  transformed  with  plasmids  in  which  the  entire 
propeptide-encoding segment (A2-45) or smaller domains 
were  deleted.  Cells  were  converted  to  spheroplasts,  la- 
beled with [35S]methionine and subjected to a differential 
osmotic lysis procedure which ruptures the plasma mem- 
brane while maintaining the integrity of the vacuole (Scott 
and  Klionsky,  1995).  The lysed  spheroplasts were  sepa- 
rated into membrane pellet and supernatant fractions, as 
described in Materials and Methods. Each fraction was im- 
munoprecipitated  with  antiserum  to  API,  carboxypepti- 
dase Y  (CPY; vacuolar marker) and phosphoglycerate ki- 
nase  (PGK;  cytosolic  marker).  Deletion  of  the  entire 
propeptide (A2-45) resulted in accumulation of API out- 
side the vacuole in the supernatant fractions (Fig. 2). Simi- 
lar results were obtained when  10 amino acid fragments 
were deleted from either of the predicted a-helices (A4-13, 
A31-40). This suggests that targeting and/or translocation 
of API is dependent on information within the propeptide. 
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Figure 1.  Amino acid sequence  and predicted secondary struc- 
ture of the API propeptide. Chou and Fasman analysis predicts 
that the first 18 amino acids exist in an a-helix, amino acids 20 to 
24 form a 13-turn, and the last 20 amino acids of the propeptide 
form a second a-helix. (A) These structures are lined  up with 
their respective amino acid constituents.  (B) The helical wheel 
projection shows the first 20 amino acids of the API propeptide 
to indicate that the hydrophobic amino acids are arrayed prima- 
rily on one face of the helix and charged or polar amino acids pri- 
marily  on  the  other,  forming  an  amphipathic  structure.  The 
amino acids and their respective characteristics  are represented 
as follows: hydrophobic 0; charged ©; and polar •. 
The Amphipathic a-Helix Contains 
Targeting Information 
The deletion  of large  stretches  of amino  acids  from the 
propeptide could cause significant  alterations  in the sec- 
ondary or tertiary structure of other targeting domains of 
the API protein and induce missorting events. To further 
characterize the targeting information and minimize struc- 
tural  alterations,  random  mutagenesis  was  employed  to 
generate point mutants.  Random mutations were gener- 
ated in the API propeptide through  PCR-mediated mu- 
tagenesis of the APE1 gene on a plasmid as described in 
Materials  and  Methods.  The  mutated  DNA  was  trans- 
formed into the yeast strain DYY101. We identified ,-,30 
mutants (from 600 recombinant/transformants) by West- 
ern blot analysis that were defective for API processing. 
Sequencing  of the  plasmid  DNA from yeast cells  ex- 
pressing defectively processed API revealed that all of the 
mutations  that affected API processing were in the pre- 
dicted amphipathic a-helix (Table I). The only exception 
was a  substitution  of proline  at position 22 with  leucine 
(denoted P22L). The remaining mutations were localized 
to a  region spanning amino acids 6-15  and affected pro- 
cessing  to  varying degrees  as  shown  in  Fig.  3.  In some 
cases, processing was completely blocked (Fig. 3, lane 2), 
whereas in others it was only partially affected (Fig. 3, lane 
3) or resulted in a species of intermediate molecular mass 
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Figure 2.  The API propeptide  is required  for vacuolar localiza- 
tion. DYY101 (Aapel) cells harboring a single copy plasmid en- 
coding either the wild type, A2-45, A4-13, or A31-40 forms of API 
were grown, converted  to spheroplasts,  labeled,  and  separated 
into  the  vacuolar  membrane  pellet  and  cytosolic supernatant 
fractions as described in Materials and Methods. CPY, PGK, and 
API were immunoprecipitated from both fractions and analyzed 
by SDS PAGE and autoradiography.  The relative levels of the 
different  proteins  in each  fraction  were  then quantitated  with 
phosphorimage analysis. The percent recovered in the pellet frac- 
tion was calculated by dividing the  value for the  pellet by the 
combined values for pellet plus supernatant fractions. 
between that  of the precursor and mature  forms (Fig 3, 
lane 4). Changes that would be predicted to alter the hy- 
drophobic nature  of the  amphipathic first  helix  such  as 
L8R and LllS  (Fig.  1 B) resulted  in complete blocks in 
processing.  A  similar  dramatic  block  in  processing  was 
seen when the helix was disrupted due to the substitution 
of leucine  at position  t5  with proline  (L15P). The M1V 
Table L Random Mutations in the API Propeptide 
Mutation  API Processing* 
M 1  V  Intermediate 
E2A  WT 
E3G  WT 
E6G  Complete Block 
L8R  Complete Block 
Q 1  OR  Major Block 
LI 1S  Complete Block 
K12R  ts: Major Block 
K12E  Major Block 
T14A  WT 
L15P  Intermediate 
QI6R  WT 
MI7V  WT 
P22L  Major Block 
*Phenotype is represented as follows: WT, wild type >90% mature; Complete Block, 
>90% precursor;  Major Block, ~50% precursor;  Intermediate, processing to or syn- 
thesis of a species intermediate in relative molecular mass between precursor and ma- 
ture API. 
Figure  3.  Mutations  within 
the  first  helix of  the  API 
propeptide give rise to a vari- 
ety of phenotypes. Shown is a 
9% SDS PAGE immunoblot 
of whole cell extracts, probed 
with  antiserum  to  API, de- 
picting: WT, wild type; C, complete  block to API maturation 
(A9-11); M, major block to API maturation (K12E); and I, an in- 
termediate processing or synthesis of API (M1V). The positions 
of precursor, intermediate, and mature API are indicated. 
mutation resulted in the synthesis of an intermediate-sized 
species  that  does  not  undergo  further  processing.  The 
elimination of the methionine at position 1 may result in 
diverting the translation start site to the methionine at po- 
sition 17. This start point would remove the putative first 
helix and, in a manner similar to the A4-13 deletion, would 
prevent processing of the remaining propeptide. 
The absence of a mutation in the predicted second a-helix 
that blocked API import was surprising given our initial 
results that indicated that both helices were essential for 
proper transport.  Since the initial  survey was carried out 
with deletions of ten amino acids, it is possible that dele- 
tions of this size in one helix may affect the function or 
presentation of the other helix.  Alternatively, the random 
mutagenesis may not have  been sufficiently comprehen- 
sive to reveal critical residues in the second helix.  To ad- 
dress these possibilities, a series of three-amino acid dele- 
tions that  encompass the  entire  propeptide  was created. 
Similar to the random mutagenesis results, the deletions in 
the predicted amphipathic a-helix severely impaired API 
processing (Table II; Fig. 4 A, lanes 2 and 3). In contrast, 
deletions in the second predicted a-helix had no effect on 
the processing of API (Table II; Fig. 4 A, lanes 4 and 5). 
Table H. Effects of Site Directed Mutations on API Processing/ 
Targeting 
Mutation*  API Processing*  Localization  §  Processing Kinetics[[ 
A3-5  Complete Block  N/D  None 
A6-8  Complete Block  N/D  None 
A9-11  Complete Block  Cytosolic  None 
A 12-14  Complete Block  Cytosolic  None 
A 15-17  Complete Block  Cytosolic  None 
A 18-20  Complete Block  Cytosolic  None 
A25-27  WT  N/D  N/D 
A28-30  WT  Vacuolar  N/D 
A31-33  WT  Vacuolar  WT 
A34-36  WT  Vacuolar  WT 
A37-39  WT  N/D  N/D 
A40-42  WT  N/D  N/D 
Ala 11  Complete Block  Cytosolic  None 
Ala 34  WT  Vacuolar  WT 
P22L  Major Block  Membrane  None 
*The A designation denotes the deletion of the indicated amino acids. Alall and 
Ala34 are insertion mutations.  P22L is a substitution mutation. 
*API  processing was determined by immunoblot detection from a 9% acrylamide 
SDS gel as described in Fig. 4. 
%ocalizatiou of API mutants was based on the percent API present in the supernatant 
fraction versus total of the supematant and the vacuole containing pellet fraction as 
described in Fig. 5. 
IIprocessing kinetics were examined by pulse chase analysis of DYY101  cells ex- 
pressing mutated forms of API as described in Fig. 6. In the case of processing-defec- 
tive mutations,  rates of propeptide cleavage were indeterminable (None). 
N/D, not determined. 
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API is affected by mutations 
that  alter  the  predicted  first 
a-helix and I3-turn but not by 
mutations  within  the  pre- 
dicted  second a-helix.  Sam- 
ples  were  prepared  from 
whole  cell  extracts  from 
DYY101  (dapel)  cells  har- 
boring a single copy plasmid 
encoding the different forms 
of API as indicated.  Protein 
extracts  were  prepared  and 
examined by immunoblot us- 
ing antiserum against API as 
described  in  Materials  and 
Methods.  (B)  The  process- 
ing of the  second helix  mu- 
tants is a proteinase A-depen- 
dent  event.  Protein  extracts 
were prepared from MOY101 
cells  (  Aapel Apep4) harbor- 
ing single  copy plasmids  en- 
coding the different forms of 
API. Proteins were resolved 
by 9% SDS PAGE and API 
was detected by immunoblot. 
(C)  The  point  mutation 
K12R imparts a temperature 
sensitive  defect for API pro- 
cessing.  DYY101  yeast cells 
containing a single copy plas- 
mid  expressing  either  wild 
type  or  the  K12R  mutant 
API were grown overnight at 
30 or 39°C in SMD. Protein 
extracts  were  obtained  by 
glass  bead  lysis  and  the  re- 
sultant samples were examined by 9% SDS PAGE and immunoblot. (D) The K12R mutant precursor API accumulated at 39°C is ac- 
cessible to the cytosol. Spheroplasts were prepared from DYY101 cells expressing the K12R mutant API and TVY1 (zlpep4) cells con- 
taining the wild-type API-encoding  plasmid pfBAPIcAX grown at 39°C. The spheroplasts were subjected to differential osmotic lysis to 
preserve vacuolar integrity. The total lysate was divided into two fractions, untreated and proteinase K treated (50 i~g/ml final concen- 
tration). Both fractions were resolved by 9% SDS PAGE and API was detected by immunoblot. The positions of precursor, mature, 
and intermediate API are indicated. 
API is  processed  in  the  vacuole from its  precursor  to 
mature form by the enzyme proteinase B  (PrB) (Klionsky 
et  al.,  1992).  PrB  maturation  is  dependent  on  the PEP4 
gene product proteinase  A  (PrA)  so that  Apep4 mutants 
accumulate precursor API. To determine whether the API 
second helix mutations (Ala34, A31-33, and A34-36) were 
being processed in the vacuole we examined maturation in 
a Aapel Apep4 strain (MOY101). Whole cell extracts from 
the  Aapel  Apep4  cells  harboring plasmids  encoding mu- 
tant API were examined by SDS PAGE and immunoblot 
analysis (Fig. 4 B). While the mutant API are processed to 
the mature form in a PEP4 strain they are not processed in 
the Apep4 strain (Fig. 4 A, lanes 4, 5, and 7 and Fig. 4  B, 
lanes  3, 4,  and 6),  indicating  that  processing  of the  API 
second helix mutants is PEP4 dependent. 
Disruption  of  the  putative  13-turn  by  substituting  the 
13-turn  initiating amino acid proline with the 13-turn  termi- 
nating amino acid leucine (P22L) resulted in a mutant ex- 
hibiting  a  severe  block  in  processing  (Fig.  4  A,  lane  8). 
Similarly,  disrupting  the  periodicity  of  the  first  amphi- 
pathic  a-helix  by  insertion  of an  alanine  at  position  11 
(Alall)  caused a  loss of processing (Fig. 4 A, lane 6).  In 
contrast, when the periodicity of the second helix was sim- 
ilarly disrupted there was no apparent change in API pro- 
cessing as was seen with the Ala34 mutation (insertion of 
an alanine at position 34; Fig. 4 A, lane 7). These results in- 
dicate that API targeting is sensitive to changes in period- 
icity and content of the predicted amphipathic a-helix but 
insensitive to similar changes in the second helix, 
A  Conditional Mutant Identifies a Highly Sensitive 
Amino Acid within the Amphipathic a-Helix 
Among  the  random  mutations  in  the  API  propeptide, 
K12E caused a  major block in API processing (Table  I). 
This result suggests that the specific charge and/or size of 
this  residue  are  important  for correct vacuolar  localiza- 
tion. During the course of examination of the random mu- 
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ined  by  SDS  PAGE  and  Western  blot  analysis  after 
growth at 39 and at 30°C.  From this survey we found one 
mutant  which  caused  a  temperature  sensitive  defect for 
API processing (Fig. 4 C). This mutant was the result of a 
substitution of a lysine residue at position 12 for arginine 
(K12R). 
To determine if the accumulated precursor form of the 
K12R  point  mutant  is  cytosolic  or  vacuolar,  DYY101 
(Aapel)  cells  expressing  the  K12R  point  mutant  and 
TVY1 (Apep4) cells containing a wild type API encoding 
plasmid were  grown  at  39°C,  converted to spheroplasts, 
and subjected to differential osmotic lysis to preserve the 
integrity  of  the  vacuole.  The  lysed  spheroplasts  were 
treated with proteinase K  and  analyzed by Western blot 
(Fig. 4 D); under these conditions cytosolic precursor API 
is cleaved to  the  mature  size, while mature  API is rela- 
tively resistant to degradation (Harding et al., 1995).  The 
precursor form of the K12R point mutant API was sensi- 
tive to proteinase K  digestion  (Fig.  4  D,  lanes 1  and 2), 
suggesting  that  it is  not  enclosed  in  a  membrane-bound 
compartment and  faces the  cytosol. The  integrity of the 
vacuoles in these preparations was confirmed by examin- 
ing the proteinase K-sensitivity of API in the Apep4 cells 
(TVY1)  expressing  wild-type  API.  API  expressed  in  a 
zlpep4 strain enters the vacuole but is not processed. The 
precursor form of API in the zlpep4 cells is protected from 
degradation (Fig. 4 D, lanes 3 and 4) indicating its localiza- 
tion within the vacuole. The presence of an intermediate 
species may be due to vacuolar lysis during sample prepa- 
ration.  The  import  and  processing  defect  seen  with  the 
K12R mutant suggests that the presence of a basic residue 
at this position is not sufficient for proper function; there 
may be a strict size limitation for this part of the helix. 
Localization  of  API Mutants 
To examine the  localization of the  API propeptide mu- 
tants,  subcellular  fractionation  experiments  were  per- 
formed. DYY101 ceils containing plasmids encoding wild 
type or altered forms of API were converted to sphero- 
plasts and  were  subjected  to differential osmotic lysis to 
preserve  the  integrity  of the  vacuole.  The  lysed sphero- 
plasts were then separated into membrane pellet and su- 
pernatant  fractions.  Each  fraction was examined  for the 
presence  of  API  and  both  the  vacuolar  and  cytosolic 
marker proteins, PrA and PGK, respectively. Efficient ly- 
sis of spheroplasts  was reflected in  the  recovery of only 
20% of the PGK in the pellet fraction. Conversely, the re- 
covery of greater than 80% of the soluble vacuolar hydro- 
lase PrA in the pellet fraction is indicative of a high yield 
of intact vacuoles (Fig. 5 A). Mutations in the first helix re- 
sulted  in  accumulation of precursor API in  the superna- 
tant fraction, while those in the 13-turn or second helix re- 
suited  in mature API localizing to the  pellet (containing 
vacuoles) fraction (Fig. 5). 
To further examine the location of API, we carried out a 
proteinase  K  sensitivity assay. After differential  osmotic 
lysis (Fig. 5 A), the samples were incubated with protease 
in the presence or absence of the detergent TX-100 (Fig. 5 
B). Mature API is relatively resistant to degradation under 
these conditions, while precursor API is cleaved to the ma- 
Figure 5.  The processing defect in API propeptide mutants is due 
to the inability  of the API molecule  to enter the vacuole.  (A) 
Fractionation of API propeptide mutants.  DYY101 (Aapel) cells 
containing  plasmids  encoding  versions  of  API  with  altered 
propeptides were separated into membrane pellet and superna- 
tant fractions  as described  in Materials  and Methods.  The pres- 
ence of the vacuolar marker enzyme PrA, the cytosolic marker 
enzyme PGK, and API were detected in the pellet and superna- 
tant fractions by immunoblotting.  (B) Protease sensitivity assay 
of API propeptide mutants. DYY101  cells containing  a  single 
copy plasmid encoding  the mutated forms of API were fraction- 
ated into T, total; S, cytosolic supernatant; and P, vacuolar pellet 
fractions,  as described  in Materials  and Methods.  The total frac- 
tion  was  further  divided  into  thirds:  untreated,  proteinase  K 
treated (50 ixg/ml final concentration), and proteinase K + TX- 
100 (0.2%)  treated. Samples were resolved by SDS PAGE and 
detected by Western blot using antiserum to API. The A12-14, 
A15-17, Alall, and L15P mutations gave results essentially iden- 
tical to A9-11; A28-30, A34-36, and Ala34 were like A31-33. 
ture size (Harding et al.,  1995).  Mutations  in the  amphi- 
pathic c~-helix generated precursor API that was sensitive 
to protease in the absence of detergent (Fig. 5 B, lane 4). 
This indicated that these altered proteins were not accu- 
mulating within  a  membrane-enclosed compartment and 
were present in the cytosol. Analysis of the P22L mutant 
showed that although it fractionated with the pellet frac- 
tion (Fig. 5 A and Fig. 5 B, lanes 7 and 8), it was accessible 
to proteolytic digestion in the absence of detergent (Fig. 5 
B, lane 9). This indicated  that the P22L mutant also was 
not enclosed in a membrane-bound compartment and may 
have been associating with the cytosolic face of the vacu- 
olar membrane. Mutations in the second helix, as exempli- 
fied by A31-33,  did not affect localization of API. Just as 
the wild type API, the mature form of the protein gener- 
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teinase K  in the absence or presence of detergent (Hard- 
ing et al., 1995; Fig. 5 B, lanes 14 and 15). 
Second Helix Mutants Are Processed with 
Wild-type Kinetics 
Mutations in the second helix of the propeptide did not af- 
fect  API  processing  under  steady  state  conditions.  It is 
possible, however, that these mutations significantly slowed 
the rate of vacuolar import. To address this possibility we 
carried out a kinetic analysis of processing. Yeast cells har- 
boring a plasmid containing either a wild-type copy of the 
APE1 gene or a copy with a mutation in the sequence en- 
coding the second helix were labeled with [35S]methionine 
for 20 min and subjected to a nonradioactive chase for 0-90 
min. The second helix mutants showed a rate of processing 
similar to that of wild-type API, implying a normal rate of 
vacuolar entry (Fig. 6). 
Mutations in the Propeptide Do Not Alter Folding 
of  APl 
Many proteins, including subtilisin (Zhu et al., 1989), PrA 
(Van  den  Hazel et  al.,  1993;  Shinde  and  Inouye,  1995), 
CPY (Winther et al., 1994), and oL-lytic  protease (Silen and 
Agard, 1989) contain internal chaperones; domains within 
the protein which function to initiate proper folding. Be- 
cause API is imported to the vacuole posttranslationally, 
one possible role for the propeptide could be to maintain 
the protein in an import-compatible conformation. If this 
is the case, alterations in the propeptide could affect fold- 
ing  of the  mature  domain.  To  determine  if the  amphi- 
pathic  a-helix had  a  chaperone function,  we studied  the 
folding state of the API mutants through limited protease 
digestion experiments. 
API proteins  with  wild-type  or altered  propeptide se- 
quences were subjected to limited digestion with protein- 
ase K  and papain under native conditions as described in 
Materials and Methods. In all propeptide mutants studied, 
the proteinase K digestion produced a product with a rela- 
tive molecular mass equivalent to mature API (Fig. 7 A), 
implying proper folding of the mature portion of API and 
retention  of its  protease-resistant character.  In  contrast, 
the  API 5-4 mutant,  which  has  no mutations  within  the 
propeptide  encoding  sequence  but  contains  four  amino 
acid substitutions within the mature portion of the protein 
(N48D,  Y49H,  F73L,  and  W91R),  was  completely  de- 
graded under these conditions  (Fig. 7 A, lane 10).  In the 
papain digest (Fig. 7 B) the wild type and propeptide mu- 
tant API were digested from the precursor relative molec- 
ular mass of 61  kD down to a  size of 58 kD. The 58-kD 
species does not have a relative molecular mass equivalent 
to mature (50 kD) but is of an intermediate size. The 5-4 
mutant was again completely degraded (Fig. 7 B, lane 10). 
The papain digest results confirm the proteinase K  digest 
results  which  indicate  that  even  with  mutations  in  the 
propeptide,  the  mature  portion  of API  assumes  a  wild- 
type stability and is thus folded properly. 
Mutations in the First a-Helix Are Defective in 
Membrane Association 
Previous studies have demonstrated that although API has 
a  half-time  for  maturation  of  30-45  min,  a  significant 
amount of newly synthesized API is membrane-associated 
Figure 6.  API processing kinetics are unaffected by mutations in 
the second helix of the API propeptide. DYY101 (Aapel) yeast 
cells containing  a single copy plasmid expressing wild-type API, 
the A9-11 deletion, and the A31-33 deletion were radiolabeled for 
20 min and subjected  to a nonradioactive chase. At the indicated 
time points an aliquot was removed and precipitated with TCA. 
Protein extracts were prepared and immunoprecipitated with an- 
tiserum to API as described in Materials  and Methods. 
Figure 7.  Mutations  in the propeptide do not affect folding  of 
API.  DYY101  (/lapel)  cells  expressing  the  wild  type,  A9-11, 
P22L, A31-33, and 5-4 forms of API from a single copy plasmid 
were converted to spheroplasts and radiolabeled for 15 min. The 
spheroplasts were pelleted and lysed by resuspending  in 50 mM 
Tris, pH 7.5, 10 mM EDTA, 0.2% TX-100 for proteinase K or 50 
mM Tris, pH 6.8, 0.2% TX-100 for papain.  Native proteins were 
subjected  to digestion  with either proteinase K (50 izg/ml final 
concentration) at 4°C or papain (50 ~g/ml final concentration)  at 
37°C, A and B, respectively.  API was subsequently  immunopre- 
cipitated as described in Materials  and Methods.  Both panels are 
composites of two gels. 
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ated API is competent for translocation into the vacuole in 
a  subsequent in vitro chase reaction (Scott and Klionsky, 
1995), the observed pool of membrane-associated precur- 
sor must be on the protein import pathway. To determine 
if the  predicted  first  helix  of the  API propeptide  is  in- 
volved in  membrane  association,  we  performed binding 
studies  with  the  collection  of API  propeptide  mutants. 
Spheroplasts were pulse labeled for 5  min and then sub- 
jected to differential osmotic lysis in a buffer containing a 
physiological concentration of potassium salts. This method 
tyses the plasma membrane while maintaining the  integ- 
rity of the vacuole, like the differential lysis procedure of 
Fig. 5 (Scott and Klionsky, 1995). The presence of physio- 
logical salt, however, preserves the interaction of API with 
the membrane fraction, and the population of API exam- 
ined here was newly synthesized. In ceils containing either 
a wild-type copy of API or the second helix deletion A31- 
33,  over 50%  of the  labeled  API  was  recovered  in  the 
membrane pellet fraction (Fig. 8 A). When the same ex- 
periment was performed in cells containing the first helix 
mutants A9-11, A12-14, and Alall, the amount of API re- 
covered in the membrane pellet fraction was greatly reduced, 
suggesting that these mutants are defective in membrane 
recognition. Interestingly, the P22L mutation shows a wild- 
type level of membrane interaction. 
In  vitro  chase  reactions  were  performed  to  examine 
whether the bound precursor in these cells was competent 
to  chase  into  the  vacuole.  Membrane  pellets containing 
bound precursor were resuspended in import buffer con- 
taining ATP and an ATP regenerating system and allowed 
to import at 30°C for 2 h  (Scott and Klionsky, 1995).  The 
only labeled API in these reactions is contributed by the 
membrane pellet. In both wild-type API and A31-33 con- 
taining cells, N50% of the bound API was matured (Fig. 8 
B). In contrast, the membrane bound P22L was defective 
in translocation into the vacuole. As expected, the first he- 
lix mutants, A9-11, A12-14,  and Alall, which are defective 
for maturation in vivo were also defective in vitro, and ma- 
tured only minimal levels of the bound precursor API. The 
in vitro chase reaction indicates that even the lower levels 
of precursor API that bound in the pellet fraction with the 
first helix mutations  (Fig.  8  A), were not  competent for 
translocation into the vacuole. This could be because the 
low level of binding observed in the mutants is nonproduc- 
tive or because the pro-region is also important for a sub- 
sequent step on the import pathway, as suggested by the 
results with the P22L mutation. 
Figure 8.  Mutations in the first helix of the API pro-region block 
the  membrane  recognition  step  of  the  import  process.  (A) 
Spheroplasts  containing  the indicated  API constructs  were pulse 
labeled for 5 rain,  subjected  to differential  osmotic lysis in IB, 
separated into pellet and supernatant fractions, and immunopre- 
cipitated with anti-API antibodies  as described  in Materials and 
Methods. The percent of API precursor in the pellet fraction was 
calculated  by comparing the amount of API in the pellet fraction 
to the sum of the API recovered in the supernatant and pellet 
fractions. (B) Pellet fractions from the experiment in A were sub- 
jected to in vitro import procedures as described  in Materials  and 
Methods.  The percent mature API was calculated by dividing the 
amount of mature recovered after import by the sum of the pre- 
cursor and mature forms recovered after import. 
Discussion 
We sought to identify the vacuolar targeting determinant 
within API for use as a  tool to examine the mechanisms 
underlying the  Cvt pathway. Since the vacuole targeting 
determinants  of the  known  soluble  vacuolar  hydrolases 
are within their respective propeptides, we turned our at- 
tention to the API propeptide. Deletion of either the en- 
tire propeptide or 10-amino acid segments from within ei- 
ther of the two predicted ct-helices abrogated delivery of 
API to the vacuolar lumen (Fig. 2). These results implicate 
the API propeptide in directing API to the vacuole. A  se- 
ries of 3-amino acid deletions across the API propeptide, 
site-directed insertions of alanine, and a random mutagen- 
esis survey of the API propeptide revealed that the puta- 
tive amphipathic t~-helix and ~-turn are sensitive to change. 
Both  random and  site-directed mutagenesis showed that 
all substitutions that interfered with API processing were 
within the predicted amphipathic ~t-helix  (Table I and II), 
with only one exception (P22L). Many of the amino acid 
substitutions  within  the  propeptide  that  disrupted  API 
processing were changes that substituted a charged amino 
acid for a  nonpolar amino acid (Table I), suggesting that 
API processing is sensitive to changes which either obliter- 
ate or mask the amphipathic nature of the first a-helix. 
The essential role of the first helix for vacuolar localiza- 
tion of API is supported by the alanine insertion mutants. 
Insertion of an alanine  at position  11 severely interfered 
with both API processing and vacuolar entry but insertion 
of an alanine at position 34 had no effect on API sorting or 
processing (Fig. 4 A, lanes 6 and 7). From these results we 
conclude that the periodicity of the amphipathic a-helix is 
essential  for  both  API  processing  and  vacuolar  import, 
whereas the periodicity of the second helix does not signif- 
icantly contribute to these events. Rather, the role of the 
second helix may be to present the amphipathic a-helix in 
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chinery. 
The screening method we employed after random mu- 
tagenesis  was  biased  toward  detecting  mutants  that  af- 
fected API processing. For a  comprehensive analysis we 
also employed site directed mutagenesis as a means of me- 
thodically examining the propeptide for regions both sen- 
sitive and insensitive to change. The findings of this study 
generally mirrored the findings of the random mutagene- 
sis survey; all mutations affecting targeting were located in 
the first predicted helix or [3-turn (Tables I and II). In ad- 
dition we found that deletion of amino acids 15-17 or 18- 
20 blocked import (Table II). This region was not identi- 
fied in the random mutagenesis survey and these deletions 
may be affecting API processing by altering the facing of 
the hydrophobic side of the amphipathic a-helix relative 
to  the  predicted  13-turn. Alternatively,  it  is  conceivable 
that amino acids 1-15 may need to be a minimum number 
of residues away from the 13-turn to allow recognition. Fi- 
nally, it is possible that the original random mutagenesis 
survey may not  have been exhaustive  enough  to  reveal 
amino acids 15-20 as sensitive to substitution. 
To ascertain the cause of the API processing defect re- 
sulting  from  alterations  in  the  first  predicted  helix  we 
examined both the localization of API (Fig. 5) and the na- 
ture of any membrane interactions (Fig. 8). Lysis in the ab- 
sence of physiological salts disrupts  any binding interac- 
tions  between  extra-vacuolar  precursor  API  and  the 
vacuole membrane. Lysis under these conditions allows an 
assessment of vacuolar localization.  By this criterion,  alter- 
ations in the first helix prevent API from entering the vac- 
uole. Protease sensitivity studies confirmed that these API 
proteins were accessible in the cytosol (Fig. 5). In the pres- 
ence of physiological salts precursor API that is bound to 
the membrane remains bound (Scott and Klionsky, 1995). 
This material can be examined in subsequent in vitro im- 
port reactions to determine if it is competent for import. 
Alterations in the first helix of the propeptide resulted in 
reduced  and nonproductive binding interactions because 
the low level of bound precursor was not imported in vitro. 
The discovery that the API propeptide contains a vacu- 
olar sorting determinant prompted us to construct a num- 
ber of fusion proteins to demonstrate that the propeptide 
is sufficient for vacuolar localization. All attempts at fus- 
ing the API propeptide to other molecules, such as inver- 
tase, failed to carry the passenger molecule into the vacu- 
ole (data not shown). Failure to target a passenger protein 
implies that the import pathway or signal of API may be 
complex, requiring more than one targeting determinant 
to be present. Preliminary data indicate that a second tar- 
geting  determinant  may reside  in  the  carboxyl-terminal 
third of API, because COOH-terminal truncations of API 
block entry into the vacuole (data not shown). 
Given the breadth of knowledge of propeptide function 
in  other proteins,  we can propose a  number of possible 
roles for the propeptide in API sorting. The most obvious 
is  the  possibility that  the  amphipathic  a-helix  acts  as  a 
sorting signal, which interacts directly with either a cytoso- 
lic factor, the vacuolar membrane, or a membrane-bound 
receptor.  The  fact that  mutations  in  the  first  helix  pre- 
vented productive binding interactions from taking place 
(Fig. 8) suggests that the amphipathic et-helix of the API 
propeptide is necessary for the proper interaction of API 
with the vacuolar membrane. 
An alternative possibility is that the propeptide serves 
as an intramolecular chaperone  and maintains  API in  a 
transloeation-compatible state. The appearance of charged 
amino acids and a-helical structures is common to domains 
that  have  chaperone  activity  (Winther  and  Sorenson, 
1991).  The observation that alterations in the propeptide 
did not affect folding or stability of API (as assessed by 
protease sensitivity; Fig. 7), however, argue against a role 
for the propeptide in nucleating protein folding. In addi- 
tion, the fact that the vacuole is a protease-rich environ- 
ment makes it unlikely that proteins will be imported into 
this organelle in an unfolded conformation. 
Alternatively, API has been reported to exist in the vac- 
uole as a dodecamer and as a less abundant hexamer (Lof- 
tier and Rohm, 1979); the amphipathic a-helix may facilitate 
the  formation  of these  higher  order  species  as  demon- 
strated for the propeptide of Mas70p (Millar  and Shore, 
1993,  1994).  In turn these higher order species may be a 
prerequisite for vacuolar membrane interaction as in the 
import of some peroxisomal proteins (McNew and Good- 
man, 1994).  The possibility that the putative amphipathic 
a-helix is acting as a  domain of interaction with a mem- 
brane or cytosolic receptor or is driving the formation of 
higher order API complexes remains to be addressed. The 
API propeptide amphipathic a-helix contains two overlap- 
ping leucine zipper motifs; one at positions 8 and 15 and 
the other at positions 11 and 18. Since three of these four 
leucines were identified  in the  random mutagenesis sur- 
vey, this motif may play a role in the recognition of an es- 
sential component of the transport machinery. Examina- 
tion of the temperature-sensitive K12R mutation also may 
shed light on the function of the amphipathic a-helix. The 
extreme sensitivity of the lysine at position 12 implies a di- 
rect functional relevance for this amino acid or a specific 
size limitation in this region of the propeptide. This size 
limitation may reflect an interaction between this part of 
the  amphip~ithic a-helix and a  component of the import 
machinery. 
In addition to the functional relevance of the predicted 
amphipathic a-helix, our results indicate some role for the 
predicted  13-turn. The  P22L  mutation  caused  precursor 
API to associate with the vacuolar membrane even under 
conditions where the binding interaction of the wild-type 
precursor was disrupted, i.e., absence of physiological salt 
(Fig. 5; Harding et al., 1995). This suggests that P22L does 
not have the same binding properties as the wild-type pre- 
cursor. The P22L fractionation data imply that the 13-turn 
does not participate in the membrane association step of 
vacuolar entry but with a succeeding step. This phenotype 
suggests that the propeptide may have a dual function in 
vacuolar entry: vacuolar membrane association and a yet 
unidentified  subsequent  step.  Conversely,  the  putative 
second a-helix was shown to not participate in API pro- 
cessing or sorting and may only serve as a  means of ex- 
tending  the  amphipathic  a-helix  away from the  mature 
protein and preventing it from misfolding into the hydro- 
phobic core of the mature portion of API. 
We have identified a number of mutations in API that 
interfere with  its correct targeting to the vacuole. These 
mutations fall into one of three classes; those that fail to 
The Journal of Cell Biology, Volume 132, 1996  1008 bind to the vacuolar membrane, those that bind to the vac- 
uolar membrane but do not enter the vacuole, and those 
that are temperature sensitive for vacuolar delivery. These 
mutants will be useful for future studies aimed at elucidat- 
ing both the mechanism and the molecular components in- 
volved in API targeting. 
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